Vivus has revealed the initial availability of Qsymia (phentermine and topiramate extended-release) capsules CIV in 8,000 Walgreens, Costco and Duane Reade retail pharmacies in the US. Qsymia is indicated as an adjunct to a ...
Tags: Qsymia, Pharmacies, Vivus
Vivus has received approval from the US Food and Drug Administration (FDA) for its Qsymia as an adjunct to a reduced-calorie diet. Qsymia will be used to manage chronic weight in adult patients with an initial body mass index (BMI) of 30 ...
Catalent Pharma Solutions has signed a supply agreement with Vivus to supply Qsymia capsules, a proprietary combination phentermine and extended-release topiramate. Catalent Modified Release Technologies president Ian Muir said Catalent ...
Tags: Qsymia capsules, extended-release topiramate, combination therapy
Vivus has received NDA approval for TA-1790 (avanafil), indicated for the treatment of erectile dysfunction (ED), in the US. VIvus will market the product under the brand name Stendra in the US. Mitsubishi Tanabe Pharma has ...
Tags: avanafil, erectile dysfunction, pharmaceutical product